The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus

Yakup Aksoy; Yusuf Emrah Eyi

Herpes Zoster Oftalmikus Tedavisinde Antiviral İlaç Zamanlaması

Year 2014, Volume: 5 Issue: 11, - , 01.11.2014

Yakup Aksoy Yusuf Emrah Eyi

Keywords

-

References

Sayhan M B, Sezenler E, Nalbur I H, Yağcı G, Gezer E. Herpes Zoster Oftalmikus JAEMCR 2012; 3: 74-6. [CrossRef]
Catron T, Hern HG. Herpes Zoster Ophthalmicus. West J Emerg Med 2008; 9: 174-6.
Heymann AD, Chodick G, Karpati T, Kamer L, Kremer E, Green M.S, et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008; 36: 226-30. [CrossRef]
Gross G, Schöfer H, Wassilew S, Friese K, Timm A, Guthoff R, et al. Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol 2003; 26: 277-89; discussion 291-3. [CrossRef]
Schmader K, Gnann J.W. Watson C.P. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis 2008;197: 207-15. [CrossRef]
Galluzzi KE. Managing herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc 2009; 109: 7-12.

The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus

Year 2014, Volume: 5 Issue: 11, - , 01.11.2014

Yakup Aksoy Yusuf Emrah Eyi

Keywords

-

References

Sayhan M B, Sezenler E, Nalbur I H, Yağcı G, Gezer E. Herpes Zoster Oftalmikus JAEMCR 2012; 3: 74-6. [CrossRef]
Catron T, Hern HG. Herpes Zoster Ophthalmicus. West J Emerg Med 2008; 9: 174-6.
Heymann AD, Chodick G, Karpati T, Kamer L, Kremer E, Green M.S, et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008; 36: 226-30. [CrossRef]
Gross G, Schöfer H, Wassilew S, Friese K, Timm A, Guthoff R, et al. Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol 2003; 26: 277-89; discussion 291-3. [CrossRef]
Schmader K, Gnann J.W. Watson C.P. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis 2008;197: 207-15. [CrossRef]
Galluzzi KE. Managing herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc 2009; 109: 7-12.

There are 6 citations in total.

Details

Other ID	JA64EG75EF
Journal Section	Letter to Editor
Authors	Yakup Aksoy This is me Yusuf Emrah Eyi This is me
Publication Date	November 1, 2014
Submission Date	November 1, 2014
Published in Issue	Year 2014 Volume: 5 Issue: 11

Cite

APA	Aksoy, Y., & Eyi, Y. E. (2014). The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus. Journal of Emergency Medicine Case Reports, 5(11).
AMA	Aksoy Y, Eyi YE. The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus. Journal of Emergency Medicine Case Reports. November 2014;5(11).
Chicago	Aksoy, Yakup, and Yusuf Emrah Eyi. “The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus”. Journal of Emergency Medicine Case Reports 5, no. 11 (November 2014).
EndNote	Aksoy Y, Eyi YE (November 1, 2014) The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus. Journal of Emergency Medicine Case Reports 5 11
IEEE	Y. Aksoy and Y. E. Eyi, “The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus”, Journal of Emergency Medicine Case Reports, vol. 5, no. 11, 2014.
ISNAD	Aksoy, Yakup - Eyi, Yusuf Emrah. “The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus”. Journal of Emergency Medicine Case Reports 5/11 (November 2014).
JAMA	Aksoy Y, Eyi YE. The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus. Journal of Emergency Medicine Case Reports. 2014;5.
MLA	Aksoy, Yakup and Yusuf Emrah Eyi. “The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus”. Journal of Emergency Medicine Case Reports, vol. 5, no. 11, 2014.
Vancouver	Aksoy Y, Eyi YE. The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus. Journal of Emergency Medicine Case Reports. 2014;5(11).